mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.01 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.01 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |